In support of the new Impact Assessment Act, the Impact Assessment Agency of Canada has redesigned and implemented a new Canadian Impact Assessment Registry. Learn more about the new Registry.

Registry Search Mobile

Registry Search

Expansion of a Sterile Injectable Medication Manufacturing Plant Project

Sandoz Canada is proposing to expand its Boucherville sterile injectable medication manufacturing plant by adding a production unit with an area of about 6,880 square metres southwest of the existing building. The Sandoz plant's production would gradually increase by 2022, from 370 to 700 metric tonnes, following the expansion project. The proposed project would also include the relocation of the access road and drainage ditches as well as the development of traffic and parking areas, sewer manholes and a culvert.


Disclaimer

This map is for illustrative purposes. The markers represent the approximate locations based on available data. More than one marker may be identified for a given project.


Latest update

The assessment is in progress.

List all documents

Contacts

  • Impact Assessment Agency of Canada
  • 22nd Floor, Place Bell
  • Ottawa, ON, K1A 0H3
  • Telephone: 613-957-0700 or 1-866-582-1884
  • Fax: 613-957-0862
  • Email: ceaa.information.acee@canada.ca

  • Location

    • Boucherville (Quebec)
  • Project Type

    • Building and Property Development
  • Status

    Completed
  • Proponent

    Sandoz Canada
  • Authorities

    • Canadian Environmental Assessment Agency
  • Assessment Type

    Assessment not applicable
  • Reference Number

    80037
Date modified: